Gebauer Mathias, Saas Joachim, Haag Jochen, Dietz Uwe, Takigawa Masaharu, Bartnik Eckart, Aigner Thomas
Aventis Pharma Deutschland, Functional Genomics, Sanofi-Aventis, Frankfurt, Germany.
Arthritis Res Ther. 2005;7(2):R274-84. doi: 10.1186/ar1479. Epub 2005 Jan 11.
Osteoarthritis is the most common degenerative disorder of the modern world. However, many basic cellular features and molecular processes of the disease are poorly understood. In the present study we used oligonucleotide-based microarray analysis of genes of known or assumed relevance to the cellular phenotype to screen for relevant differences in gene expression between normal and osteoarthritic chondrocytes. Custom made oligonucleotide DNA arrays were used to screen for differentially expressed genes in normal (n = 9) and osteoarthritic (n = 10) cartilage samples. Real-time polymerase chain reaction (PCR) with gene-specific primers was used for quantification. Primary human adult articular chondrocytes and chondrosarcoma cell line HCS-2/8 were used to study changes in gene expression levels after stimulation with interleukin-1beta and bone morphogenetic protein, as well as the dependence on cell differentiation. In situ hybridization with a gene-specific probe was applied to detect mRNA expression levels in fetal growth plate cartilage. Overall, more than 200 significantly regulated genes were detected between normal and osteoarthritic cartilage (P < 0.01). One of the significantly repressed genes, Tob1, encodes a protein belonging to a family involved in silencing cells in terms of proliferation and functional activity. The repression of Tob1 was confirmed by quantitative PCR and correlated to markers of chondrocyte activity and proliferation in vivo. Tob1 expression was also detected at a decreased level in isolated chondrocytes and in the chondrosarcoma cell line HCS-2/8. Again, in these cells it was negatively correlated with proliferative activity and positively with cellular differentiation. Altogether, the downregulation of the expression of Tob1 in osteoarthritic chondrocytes might be an important aspect of the cellular processes taking place during osteoarthritic cartilage degeneration. Activation, the reinitiation of proliferative activity and the loss of a stable phenotype are three major changes in osteoarthritic chondrocytes that are highly significantly correlated with the repression of Tob1 expression.
骨关节炎是现代社会最常见的退行性疾病。然而,该疾病的许多基本细胞特征和分子过程仍知之甚少。在本研究中,我们使用基于寡核苷酸的微阵列分析已知或假定与细胞表型相关的基因,以筛选正常和骨关节炎软骨细胞之间基因表达的相关差异。定制的寡核苷酸DNA阵列用于筛选正常(n = 9)和骨关节炎(n = 10)软骨样本中差异表达的基因。使用基因特异性引物的实时聚合酶链反应(PCR)进行定量分析。原代成人关节软骨细胞和软骨肉瘤细胞系HCS-2/8用于研究白细胞介素-1β和骨形态发生蛋白刺激后基因表达水平的变化,以及对细胞分化的依赖性。应用基因特异性探针的原位杂交检测胎儿生长板软骨中的mRNA表达水平。总体而言,在正常和骨关节炎软骨之间检测到200多个显著调控的基因(P < 0.01)。其中一个显著下调的基因Tob1编码一种蛋白质,该蛋白质属于一个在细胞增殖和功能活性方面参与细胞沉默的家族。Tob1的下调通过定量PCR得到证实,并与体内软骨细胞活性和增殖的标志物相关。在分离的软骨细胞和软骨肉瘤细胞系HCS-2/8中也检测到Tob1表达水平降低。同样,在这些细胞中,它与增殖活性呈负相关,与细胞分化呈正相关。总之,骨关节炎软骨细胞中Tob1表达的下调可能是骨关节炎软骨退变过程中发生的细胞过程的一个重要方面。激活、增殖活性的重新启动和稳定表型的丧失是骨关节炎软骨细胞的三个主要变化,与Tob1表达的下调高度显著相关。